Shares of Aurora Cannabis Inc. ACB slipped 4.28% to $6.04 Tuesday, on what proved to be an all-around positive trading ...

Jan. 28, 2025 — A new study explores the effects of both recent and lifetime cannabis use on brain function during cognitive tasks. The study, the largest of its kind ever to be completed ...

For all the ways Colorado’s cannabis industry has evolved over the decade-plus since legalization, one thing that remains largely the same is the consumer buying experience. A Denver company aims ...

Innocan Pharma Corporation ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce the successful outcome from the compassionate treatment of ...

Aurora Cannabis has shifted focus to the medical cannabis market, achieving higher gross margins. Read why I upgrade ACB ...

Investing.com -- Shares of Aurora Cannabis (TSX:ACB) Inc. (NASDAQ: NASDAQ:ACB) (TSX: ACB) soared 40% following the announcement of its fiscal 2025 third-quarter results. The Edmonton-based company ...

Aurora Cannabis (NASDAQ: ACB) surged 45% after reporting record earnings, boosting CGC, TLRY, and CRON stocks.

Aurora Cannabis Inc. (ACB) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to loss of $0.20 per share a year ago.

(1) Working capital for the three months ended December 31, 2024 has been adjusted. Refer to discussion under "Liquidity and Capital Resources" section of the MD&A.

Aurora Cannabis (ACB) stock surges 27% in premarket after reporting strong Q3 fiscal 2025 results with record-breaking revenue and profitability. Read more here.